Singapore legislation

Schedule 5

of Health Products (Therapeutic Products) Regulations 2016

Schedule 5

Cautionary information to be labelled on therapeutic products

FIFTH SCHEDULERegulation 20(3)Cautionary information to be labelled on therapeutic productsFirst column Second columnTherapeutic product Cautionary information

1. Therapeutic product containing aspirin or acetylsalicylic acid for oral administration Caution: Not to be given to persons below 16 years of age except under the direction of a doctor.2.Therapeutic product containing any of the following substances for oral administration: Caution: This may cause drowsiness. If affected, do not drive or operate machinery.(a)Diphenoxylate (b)Loperamide (c)The following anti‑histamine substances: Antazoline Azatadine Bamipine Bromodiphenhydramine Bromopheniramine Buclizine Carbinoxamine Chlorcyclizine Chlorpheniramine Cinnarizine Clemastine Clemizole Cyclizine Cyproheptadine Dexchlorpheniramine Dimethpyrindene Diphenhydramine Diphenylpyraline Doxylamine Embramine Flunarizine Homochlorcyclizine Isothipendyl Levocabastine Mebhydrolin Meclastine Meclozine Mepyramine Mequitazine Methdilazine Oxatomide Oxomemazine Phenindamine Pheniramine Phenyltoloxamine Promethazine Pyrathiazine Pyrrobutamine Thenalidine Thenyldiamine Thiazinamium Tolpropamine Tripelennamine Triprolidine